Search Within

Terence John Purdon

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Meeting Abstract (15)
  2. Journal Article (9)
Groups
  1. Adult Leukemia (24)
  2. Center for Hematologic Malignancies (24)
  3. Department of Medicine (24)
  4. GSK Faculty (24)
  5. Hematologic Malignancies Research (24)
  6. Hematologic Malignancies, Division of (24)

More Groups

People
  1. Renier Brentjens (23)
  2. Sarwish Rafiq (10)
  3. Dayenne van Leeuwen (8)
  4. Hollie Pegram (7)
  5. Isabelle Riviere (7)
  6. Kevin Curran (7)

More People

Years
  1. 2022 (1)
  2. 2021 (3)
  3. 2020 (3)
  4. 2019 (2)
  5. 2018 (6)
  6. 2017 (2)

More Years

Publications
  1. Blood (6)
  2. Molecular Therapy (4)
  3. Cytotherapy (3)
  4. Leukemia (2)
  5. Blood Cancer Discovery (1)
  6. Bone Marrow Transplantation (1)

More Publications

Publishers
  1. Nature Publishing Group (9)
  2. American Society of Hematology (6)
  3. American Association for Cancer Research (4)
  4. Elsevier Science Ltd. (3)
  5. American Association for the Advancement of Science (1)
  6. Cell Press (1)

Results (24)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical responses and pharmacokinetics of MCARH171, a human-derived BCMA targeted CAR T cell therapy in relapsed/refractory multiple myeloma: Final results of a phase I clinical trial
    Meeting Abstract

    Mailankody, S.; Ghosh, A.; Staehr, M.; Purdon, T. J.; Roshal, M.; Halton, E.; Diamonte, C.; Pineda, J.; Anant, P.; Bernal, Y.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Targeted delivery of a PD-1-blocking scFV by CAR-T cells enhances anti-tumor efficacy in vivo
    Journal Article

    Rafiq, S.; Yeku, O. O.; Jackson, H. J.; Purdon, T. J.; van Leeuwen, D. G.; Drakes, D. J.; Song, M.; Miele, M. M.; Li, Z.; Wang, P.; more...
    Nature Biotechnology (2018)

    Fulltext@MSK | Save
  • Clinical and biological correlates of neurotoxicity associated with CAR T-cell therapy in patients with B-cell acute lymphoblastic leukemia
    Journal Article

    Santomasso, B. D.; Park, J. H.; Salloum, D.; Riviere, I.; Flynn, J.; Mead, E.; Halton, E.; Wang, X.; Senechal, B.; Purdon, T.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • CAR T cells secreting an immune checkpoint blockade scFv have enhanced anti-tumor efficacy
    Meeting Abstract

    Rafiq, S.; Yeku, O.; Jackson, H.; Purdon, T.; van Leeuwen, D.; Yan, S.; Wang, P.; Xiang, J.; Liu, C.; Brentjens, R.
    Molecular Therapy (2018)

    Fulltext@MSK | Save
  • Engineered tumor-targeted T cells mediate enhanced anti-tumor efficacy both directly and through activation of the endogenous immune system
    Journal Article

    Avanzi, M. P.; Yeku, O.; Li, X.; Wijewarnasuriya, D. P.; van Leeuwen, D. G.; Cheung, K.; Park, H.; Purdon, T. J.; Daniyan, A. F.; Spitzer, M. H.; more...
    Cell Reports (2018)

    Fulltext@MSK | Save
  • Enhancing CAR T cell anti-tumor efficacy through secreted single chain variable fragment (scFv) immune checkpoint blockade
    Meeting Abstract

    Rafiq, S.; Jackson, H. J.; Yeku, O.; Purdon, T. J.; van Leeuwen, D. G.; Curran, K. J.; Ahmed, R. N.; Cullen, G. D.; Yan, S.; Wang, P.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen
    Journal Article

    Rafiq, S.; Purdon, T. J.; Daniyan, A. F.; Koneru, M.; Dao, T.; Liu, C.; Scheinberg, D. A.; Brentjens, R. J.
    Leukemia (2017)

    Fulltext@MSK | Save
  • IL-18 secreting CAR T cells enhance cell persistence, induce prolonged B cell aplasia and eradicate CD19+ tumor cells without need for prior conditioning
    Meeting Abstract

    Avanzi, M. P.; van Leeuwen, D. G.; Li, X.; Cheung, K.; Park, H.; Purdon, T. J.; Brentjens, R. J.
    Blood (2016)

    Fulltext@MSK | Save
  • CD33-directed chimeric antigen receptor (CAR) T cells for the treatment of acute myeloid leukemia (AML)
    Meeting Abstract

    Rafiq, S.; Purdon, T. J.; Schultz, L. M.; Brentjens, R. J.
    Blood (2016)

    Fulltext@MSK | Save
  • Engineering armored T cell receptor-mimic (TCRm) chimeric antigen receptor (CAR) T cells specific for the intracellular protein Wilms tumor 1 (WT1) for treatment of hematologic and solid malignancies
    Meeting Abstract

    Rafiq, S.; Purdon, T.; Dao, T.; Liu, C.; Scheinberg, D.; Brentjens, R. J.
    Molecular Therapy (2016)

    Fulltext@MSK | Save